Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
Pabitra Hriday Patra, Melissa Barker‐Haliski, H. Steve White, et al.
Epilepsia (2018) Vol. 60, Iss. 2, pp. 303-314
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4
Tengfei Huang, Tianqi Xu, Yangfan Wang, et al.
Autophagy (2021) Vol. 17, Iss. 11, pp. 3592-3606
Open Access | Times Cited: 152
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Valentina Franco, Emilio Perucca
Drugs (2019) Vol. 79, Iss. 13, pp. 1435-1454
Closed Access | Times Cited: 148
THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 59
Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity
Evan C. Rosenberg, Simon Chamberland, Michaël Bazelot, et al.
Neuron (2023) Vol. 111, Iss. 8, pp. 1282-1300.e8
Open Access | Times Cited: 53
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Keith Cheung, Hassendrini N. Peiris, Geoff Wallace, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6079-6079
Open Access | Times Cited: 91
Cannabidiol in the Treatment of Epilepsy
Randi von Wrede, Christoph Helmstaedter, Rainer Surges
Clinical Drug Investigation (2021) Vol. 41, Iss. 3, pp. 211-220
Open Access | Times Cited: 88
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders
Victoria M. Golub, Doodipala Samba Reddy
Advances in experimental medicine and biology (2020), pp. 93-110
Closed Access | Times Cited: 74
Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
Doodipala Samba Reddy
Experimental Neurology (2022) Vol. 359, pp. 114237-114237
Open Access | Times Cited: 50
Use of cannabidiol in the treatment of epilepsy
Maria Mazurkiewicz-Bełdzińska, Marta Zawadzka
Neurologia i Neurochirurgia Polska (2022) Vol. 56, Iss. 1, pp. 14-20
Open Access | Times Cited: 46
Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy
Eleonora Aronica, Nicola Specchio, Mark J. Luinenburg, et al.
Brain (2023) Vol. 146, Iss. 7, pp. 2694-2710
Open Access | Times Cited: 38
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening
Melissa Barker‐Haliski, H. Steve White
Neuropharmacology (2019) Vol. 167, pp. 107750-107750
Open Access | Times Cited: 64
The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights
Willian Lazarini-Lopes, Raquel A. Do Val-da Silva, Rui Milton Patrício da Silva-Júnior, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 111, pp. 166-182
Closed Access | Times Cited: 63
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Barbara Malinowska, Marta Baranowska‐Kuczko, Aleksandra Kicman, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1986-1986
Open Access | Times Cited: 46
Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
Lyndsey L. Anderson, Marika Heblinski, Nathan L. Absalom, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 24, pp. 4826-4841
Open Access | Times Cited: 45
Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation
Leanne M Lehmann, Alexandria Lo, Kevin M. Knox, et al.
Neurochemical Research (2021) Vol. 46, Iss. 8, pp. 1895-1912
Open Access | Times Cited: 43
Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries
Mackenzie M. Aychman, David L. Goldman, Joshua S. Kaplan
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 17
Cannabinoid treatments in epilepsy and seizure disorders
Orrin Devinsky, Nicholas A. Jones, Mark O. Cunningham, et al.
Physiological Reviews (2023) Vol. 104, Iss. 2, pp. 591-649
Closed Access | Times Cited: 17
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
Oluwadara Pelumi Omotayo, Yolandy Lemmer, Shayne Mason
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 7
Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice
Eva Maria Schleicher, Frederik Wilhelm Ott, Melanie Müller, et al.
Frontiers in Behavioral Neuroscience (2019) Vol. 13
Open Access | Times Cited: 51
Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent
Royston A. Gray, Colin Stott, Nicholas A. Jones, et al.
Cannabis and Cannabinoid Research (2019) Vol. 5, Iss. 2, pp. 145-149
Open Access | Times Cited: 50
Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy
Christopher Martínez-Aguirre, Francia Carmona-Cruz, Ana Luisa Velasco, et al.
Frontiers in Behavioral Neuroscience (2020) Vol. 14
Open Access | Times Cited: 49
Cannabidiol improves survival and behavioural co‐morbidities of Dravet syndrome in mice
Pabitra Hriday Patra, Eleni Serafeimidou‐Pouliou, Michaël Bazelot, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 12, pp. 2779-2792
Open Access | Times Cited: 45
Neuroprotective role of chrysin‐loaded poly(lactic‐co‐glycolic acid) nanoparticle against kindling‐induced epilepsy through Nrf2/ARE/HO‐1 pathway
Ying Zhang, Jing Zhao, Obaid Afzal, et al.
Journal of Biochemical and Molecular Toxicology (2020) Vol. 35, Iss. 2
Closed Access | Times Cited: 42
Epilepsy and its neurobehavioral comorbidities: Insights gained from animal models
Wolfgang Löscher, Carl E. Stafstrom
Epilepsia (2022) Vol. 64, Iss. 1, pp. 54-91
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top